Observational studyPharmacological reports : PR2023

Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study.

Juan Vicente-Valor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.